• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NMT1介导的N-肉豆蔻酰化依赖POTEE刺激肝肿瘤发生,差异调节靶标的泛素化。

N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis Differentially Regulating Ubiquitination of Targets.

作者信息

Zhu Guoqing, Wang Feng, Li Haojie, Zhang Xiao, Wu Qi, Liu Ya, Qian Mingping, Guo Susu, Yang Yueyue, Xue Xiangfei, Sun Fenyong, Qiao Yongxia, Pan Qiuhui

机构信息

Department of Clinical Laboratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

Department of Gastroenterology, Shanghai Tenth People's Hospital of Tongji University, Shanghai, China.

出版信息

Front Oncol. 2021 May 31;11:681366. doi: 10.3389/fonc.2021.681366. eCollection 2021.

DOI:10.3389/fonc.2021.681366
PMID:34136404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8201403/
Abstract

BACKGROUND

A tremendous amount of studies have suggested that post-translational modifications (PTMs) play pivotal roles during tumorigenesis. Compared to other PTMs, lipid modification is less studied. Recently, N-myristoylation, one type of lipid modification, has been paid attention to the field of cancer. However, whether and how N-myristoylation exerts its roles in liver tumorigenesis still remains unclear.

METHODS

Parallel reaction monitoring (PRM) was conducted to evaluate the expression of protein modification enzymes in paired tissues. Liver conditionally knocking NMT1 out mice model was used to assess the critical roles of N-myristoylation during liver tumorigenesis. Proteomics isobaric tags for relative and absolute quantification (iTraq) was performed to identify proteins that changed while NMT1 was knocked down. The click chemistry assay was used to evaluate the N-myristoylation levels of proteins.

RESULTS

Here, N-myristolyation and its enzyme NMT1, but not NMT2, were found to be critical in liver cancer. Two categories of proteins, i.e., N-myristolyation down-regulated proteins (NDP, including LXN, RPL29, and FAU) and N-myristolyation up-regulated proteins (NUP, including AHSG, ALB, and TF), were revealed negatively and positively regulated by NMT1, respectively. Both NDP and NUP could be N-myristolyated by NMT1 indispensable of POTEE. However, N-myristolyation decreased and increased stability of NDP and NUP, respectively. Mechanistically, NDP-specific binding protein RPL7A facilitated HIST1H4H, which has ubiquitin E3 ligase function, to ubiquitinate NDP. By contrast, NUP-specific binding protein HBB prevented NUP from ubiquitination by HIST1H4H. Notably, function of RPL7A and HBB was all NMT1-dependent. Moreover, NDP suppressed while NUP stimulated transformative phenotypes. Clinically, higher levels of NMT1 and NUP with lower levels of NDP had worse prognostic outcome.

CONCLUSION

Collectively, N-myristolyation by NMT1 suppresses anti-tumorigenic NDP, whereas it stimulates pro-tumorigenic NUP by interfering their ubiquitination to finally result in a pro-tumorigenic outcome in liver cancer. Targeting N-myristolyation and NMT1 might be helpful to treat liver cancer.

摘要

背景

大量研究表明,翻译后修饰(PTMs)在肿瘤发生过程中起关键作用。与其他翻译后修饰相比,脂质修饰的研究较少。最近,N-肉豆蔻酰化作为一种脂质修饰类型,已在癌症领域受到关注。然而,N-肉豆蔻酰化在肝癌发生中是否以及如何发挥作用仍不清楚。

方法

采用平行反应监测(PRM)评估配对组织中蛋白质修饰酶的表达。利用肝脏条件性敲除NMT1的小鼠模型评估N-肉豆蔻酰化在肝癌发生中的关键作用。进行蛋白质组学相对和绝对定量等压标签(iTraq)以鉴定NMT1敲低时发生变化的蛋白质。采用点击化学分析法评估蛋白质的N-肉豆蔻酰化水平。

结果

在此研究中,发现N-肉豆蔻酰化及其酶NMT1而非NMT2在肝癌中起关键作用。揭示了两类蛋白质,即N-肉豆蔻酰化下调蛋白(NDP,包括LXN、RPL29和FAU)和N-肉豆蔻酰化上调蛋白(NUP,包括AHSG、ALB和TF),分别受到NMT1的负调控和正调控。NDP和NUP均可被NMT1进行N-肉豆蔻酰化,这是POTEE所必需的。然而,N-肉豆蔻酰化分别降低和增加了NDP和NUP的稳定性。机制上,NDP特异性结合蛋白RPL7A促进具有泛素E3连接酶功能的HIST1H4H对NDP进行泛素化。相比之下,NUP特异性结合蛋白HBB阻止HIST1H4H对NUP进行泛素化。值得注意的是,RPL7A和HBB的功能均依赖于NMT1。此外,NDP抑制而NUP刺激转化表型。临床上,NMT1和NUP水平较高而NDP水平较低的患者预后较差。

结论

总体而言,NMT1介导的N-肉豆蔻酰化通过干扰其泛素化抑制抗肿瘤的NDP,而刺激促肿瘤的NUP,最终导致肝癌的促肿瘤结果。靶向N-肉豆蔻酰化和NMT1可能有助于治疗肝癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/d06daeb3b765/fonc-11-681366-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/c395535ee0ad/fonc-11-681366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/fcc56042c41d/fonc-11-681366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/65433b3cc7ef/fonc-11-681366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/e8f91689f2cf/fonc-11-681366-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/bc02f49cf0f1/fonc-11-681366-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/76e605c19a95/fonc-11-681366-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/b303bb772a01/fonc-11-681366-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/d06daeb3b765/fonc-11-681366-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/c395535ee0ad/fonc-11-681366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/fcc56042c41d/fonc-11-681366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/65433b3cc7ef/fonc-11-681366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/e8f91689f2cf/fonc-11-681366-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/bc02f49cf0f1/fonc-11-681366-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/76e605c19a95/fonc-11-681366-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/b303bb772a01/fonc-11-681366-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f1/8201403/d06daeb3b765/fonc-11-681366-g008.jpg

相似文献

1
N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis Differentially Regulating Ubiquitination of Targets.NMT1介导的N-肉豆蔻酰化依赖POTEE刺激肝肿瘤发生,差异调节靶标的泛素化。
Front Oncol. 2021 May 31;11:681366. doi: 10.3389/fonc.2021.681366. eCollection 2021.
2
NMT1 sustains ICAM-1 to modulate adhesion and migration of tumor cells.NMT1 维持 ICAM-1 以调节肿瘤细胞的黏附和迁移。
Cell Signal. 2023 Sep;109:110739. doi: 10.1016/j.cellsig.2023.110739. Epub 2023 Jun 1.
3
N-Myristoyltransferase isozymes exhibit differential specificity for human immunodeficiency virus type 1 Gag and Nef.N-肉豆蔻酰转移酶同工酶对1型人类免疫缺陷病毒的Gag和Nef表现出不同的特异性。
J Gen Virol. 2008 Jan;89(Pt 1):288-296. doi: 10.1099/vir.0.83412-0.
4
N-myristoylation regulates the SnRK1 pathway in Arabidopsis.N-肉豆蔻酰化调节拟南芥中的SnRK1途径。
Plant Cell. 2007 Sep;19(9):2804-21. doi: 10.1105/tpc.107.051870. Epub 2007 Sep 7.
5
TNF-α-induced Inhibition of Protein Myristoylation Binding Between NMT1 and Sorbs2 in Osteoblasts.肿瘤坏死因子-α诱导的蛋白豆蔻酰化抑制作用 破骨细胞中 NMT1 和 Sorbs2 之间的结合。
In Vivo. 2024 Jan-Feb;38(1):107-113. doi: 10.21873/invivo.13416.
6
N-myristoyltransferase in the leukocytic development processes.N-豆蔻酰转移酶在白细胞发育过程中的作用。
Cell Tissue Res. 2011 Aug;345(2):203-11. doi: 10.1007/s00441-011-1202-x. Epub 2011 Jun 24.
7
Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis.两种N-肉豆蔻酰转移酶同工酶在蛋白质肉豆蔻酰化、增殖和凋亡过程中发挥着独特作用。
Mol Cancer Res. 2005 Aug;3(8):463-76. doi: 10.1158/1541-7786.MCR-05-0037.
8
N-myristoyltransferase-1 deficiency blocks myristoylation of LAMTOR1 and inhibits bladder cancer progression.N-豆蔻酰基转移酶-1 缺乏会阻止 LAMTOR1 的豆蔻酰化,从而抑制膀胱癌的进展。
Cancer Lett. 2022 Mar 31;529:126-138. doi: 10.1016/j.canlet.2022.01.001. Epub 2022 Jan 6.
9
Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression.阻断 NMT1 的酶活性抑制 VILIP3 蛋白的 N-豆蔻酰化,从而抑制肝癌进展。
Signal Transduct Target Ther. 2023 Jan 9;8(1):14. doi: 10.1038/s41392-022-01248-9.
10
A role for Saccharomyces cerevisiae fatty acid activation protein 4 in regulating protein N-myristoylation during entry into stationary phase.酿酒酵母脂肪酸激活蛋白4在进入稳定期期间调节蛋白质N-肉豆蔻酰化中的作用。
J Biol Chem. 1998 Oct 2;273(40):25864-74. doi: 10.1074/jbc.273.40.25864.

引用本文的文献

1
Early menarche and childbirth accelerate aging-related outcomes and age-related diseases: Evidence for antagonistic pleiotropy in humans.初潮过早和分娩过早会加速与衰老相关的结果及与年龄相关的疾病:人类拮抗多效性的证据。
Elife. 2025 Aug 12;13:RP102447. doi: 10.7554/eLife.102447.
2
Protein lipidation in the tumor microenvironment: enzymology, signaling pathways, and therapeutics.肿瘤微环境中的蛋白质脂化:酶学、信号通路与治疗学
Mol Cancer. 2025 May 7;24(1):138. doi: 10.1186/s12943-025-02309-7.
3
Early menarche and childbirth accelerate aging-related outcomes and age-related diseases: Evidence for antagonistic pleiotropy in humans.

本文引用的文献

1
High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation.高分辨率的人类 N-豆蔻酰转移酶作用快照阐明了促进 N 端赖氨酸和甘氨酸豆蔻酰化的机制。
Nat Commun. 2020 Feb 28;11(1):1132. doi: 10.1038/s41467-020-14847-3.
2
NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle.NMT1 和 NMT2 是赖氨酸豆蔻酰基转移酶,调节 ARF6 GTP 酶循环。
Nat Commun. 2020 Feb 26;11(1):1067. doi: 10.1038/s41467-020-14893-x.
3
The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway.
初潮过早和分娩会加速与衰老相关的结果及与年龄相关的疾病:人类拮抗基因多效性的证据。
medRxiv. 2025 Jan 28:2024.09.23.24314197. doi: 10.1101/2024.09.23.24314197.
4
Machine-learning prediction of a novel diagnostic model using mitochondria-related genes for patients with bladder cancer.使用线粒体相关基因对膀胱癌患者进行新型诊断模型的机器学习预测。
Sci Rep. 2024 Apr 23;14(1):9282. doi: 10.1038/s41598-024-60068-9.
5
The role of N-myristoyltransferase 1 in tumour development.N-豆蔻酰转移酶 1 在肿瘤发生中的作用。
Ann Med. 2023 Dec;55(1):1422-1430. doi: 10.1080/07853890.2023.2193425.
6
SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway.SPI1 介导 N-豆蔻酰转移酶 1 通过 PI3K/AKT/mTOR 通路促进胃癌进展。
Can J Gastroenterol Hepatol. 2023 Mar 17;2023:2021515. doi: 10.1155/2023/2021515. eCollection 2023.
7
Protein acylation: mechanisms, biological functions and therapeutic targets.蛋白质酰化:机制、生物学功能和治疗靶点。
Signal Transduct Target Ther. 2022 Dec 29;7(1):396. doi: 10.1038/s41392-022-01245-y.
8
Post-Translational Modifications by Lipid Metabolites during the DNA Damage Response and Their Role in Cancer.脂质代谢物在 DNA 损伤反应中的翻译后修饰及其在癌症中的作用。
Biomolecules. 2022 Nov 8;12(11):1655. doi: 10.3390/biom12111655.
组蛋白甲基转移酶 G9a 通过调节 Hippo 通路激酶 LATS2 和 YAP 信号通路促进胆管癌发生。
Hepatology. 2020 Oct;72(4):1283-1297. doi: 10.1002/hep.31141. Epub 2020 Oct 9.
4
Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz.MYC 和 β-catenin 在肝肿瘤发生中的合作需要 yap/Taz。
Hepatology. 2020 Oct;72(4):1430-1443. doi: 10.1002/hep.31120. Epub 2020 Jul 29.
5
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis.SUMOylation 抑制剂与 FXR 激动剂协同作用抗肝纤维化。
Nat Commun. 2020 Jan 13;11(1):240. doi: 10.1038/s41467-019-14138-6.
6
POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling.POTEE 通过调控 SPHK1/p65 信号通路促进结直肠癌发生发展。
Cell Death Dis. 2019 Nov 13;10(11):863. doi: 10.1038/s41419-019-2046-7.
7
Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-κB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.中脑星形胶质细胞衍生神经营养因子通过小泛素相关修饰物(SUMO)化相关抑制 NF-κB/Snail 信号通路和上皮-间充质转化抑制肝癌。
Hepatology. 2020 Apr;71(4):1262-1278. doi: 10.1002/hep.30917. Epub 2020 Jan 26.
8
Long Noncoding RNA p53-Stabilizing and Activating RNA Promotes p53 Signaling by Inhibiting Heterogeneous Nuclear Ribonucleoprotein K deSUMOylation and Suppresses Hepatocellular Carcinoma.长链非编码 RNA p53 稳定和激活 RNA 通过抑制异质核核糖核蛋白 K 的去 SUMO 化来促进 p53 信号通路,并抑制肝癌。
Hepatology. 2020 Jan;71(1):112-129. doi: 10.1002/hep.30793. Epub 2019 Aug 12.
9
The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B.乙型肝炎病毒 X 蛋白的抗切割活性。
Hepatology. 2019 Jun;69(6):2546-2561. doi: 10.1002/hep.30571. Epub 2019 Apr 11.
10
N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation.N-豆蔻酰基转移酶缺乏会损害激酶 AMPK 的激活,并促进滑膜组织炎症。
Nat Immunol. 2019 Mar;20(3):313-325. doi: 10.1038/s41590-018-0296-7. Epub 2019 Feb 4.